Tadalafil, a long-acting prescription medication that widens blood vessels, is used for erection problems and urinary symptoms of an enlarged prostate, backed by well-run trials, and treats a rare lung-artery disease. Its longevity case remains uncertain: health-record studies link it to fewer heart attacks and deaths, but healthier habits may partly explain this. Side effects are mostly mild; combining it with heart-pain drugs called nitrates causes dangerous blood-pressure drops. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood pressure (seated and standing) | Resting at or above 90/50 mm Hg | Safety check: hypotension stops or changes use |
| Creatinine clearance or eGFR | Creatinine clearance above 50 mL/min for standard dosing | Safety check: low values change or rule out daily dose |
| Liver panel (ALT, bilirubin, albumin) | ALT 7–56 U/L | Safety check: severe impairment rules out use |
| IIEF-EF score | No established target; track change from own baseline | Expected to change with treatment |
| IPSS | No established target; track change from own baseline | Expected to change in men with prostate symptoms |
| HbA1c | 4.0–5.6% | Expected to change modestly in type 2 diabetes |
| Semen analysis (if planning conception) | Sperm concentration 16 million/mL or more | Safety check: falls may prompt stopping |
Cadence: Standing blood pressure and symptom scores at 1 and 4 weeks after starting or changing dose; then blood pressure, kidney function and symptom scores every 6–12 months; HbA1c every 6–12 months in people with diabetes; repeat semen analysis after about 3 months of use in men planning conception.